US6875872B1
(en)
*
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
ES2283012T3
(es)
|
1996-01-04 |
2007-10-16 |
Novartis Vaccines And Diagnostics, Inc. |
Bacterioferritina de helicobacter pylori.
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
SE510650C2
(sv)
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
SE9900274D0
(sv)
*
|
1999-01-28 |
1999-01-28 |
Astra Ab |
New compound
|
US6369087B1
(en)
*
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
ES2286408T3
(es)
*
|
2002-03-05 |
2007-12-01 |
Astrazeneca Ab |
Sales de alquilamonio de omeprazol e esomeprazol.
|
WO2003089408A2
(en)
*
|
2002-04-22 |
2003-10-30 |
Sun Pharmaceutical Industries Limited |
Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
|
EP1515963B1
(en)
*
|
2002-06-27 |
2007-02-14 |
Dr. Reddy's Laboratories Ltd. |
A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
|
CA2491118A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Dr. Reddy's Laboratories Limited |
A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
|
TW200410955A
(en)
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
US7612098B2
(en)
*
|
2002-08-30 |
2009-11-03 |
Dr. Reddy's Laboratories Limited |
Amorphous hydrous esomeprazole magnesium
|
EP2596792A1
(en)
*
|
2002-10-16 |
2013-05-29 |
Takeda Pharmaceutical Company Limited |
Stable solid preparations
|
EA200500673A1
(ru)
*
|
2002-10-22 |
2005-12-29 |
Рэнбакси Лабораториз Лимитед |
Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе
|
WO2004046134A2
(en)
*
|
2002-11-18 |
2004-06-03 |
Dr. Reddy's Laboratories Limited |
Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
|
EP1583507A2
(en)
*
|
2003-01-07 |
2005-10-12 |
Ranbaxy Laboratories Limited |
Magnesium salt of imidazole derivative
|
WO2004089935A1
(en)
*
|
2003-04-10 |
2004-10-21 |
Hetero Drugs Limitd |
Novel crystalline forms of s-omeprazole magnesium
|
WO2004099181A1
(en)
|
2003-05-05 |
2004-11-18 |
Ranbaxy Laboratories Limited |
Barium salt of benzimidazole derivative
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
CN100457104C
(zh)
*
|
2003-07-23 |
2009-02-04 |
尼科梅德有限责任公司 |
质子泵抑制剂的碱性盐
|
SI1651217T1
(sl)
*
|
2003-07-23 |
2008-08-31 |
Nycomed Gmbh |
Alkalne soli inhibitorjev protonske ÄŤrpalke
|
SE0302382D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts II
|
SE0302381D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts I
|
US20050075371A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Allergan, Inc. |
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
AU2005216863A1
(en)
*
|
2004-02-18 |
2005-09-09 |
Allergan, Inc. |
Methods and compositions for the intravenous administration of compounds related to proton pump inhibitors
|
JP2007523163A
(ja)
*
|
2004-02-18 |
2007-08-16 |
アラーガン、インコーポレイテッド |
プロトンポンプインヒビターのプロドラッグの投与のための方法および組成物
|
CA2561700A1
(en)
*
|
2004-04-16 |
2005-12-15 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and prokinetic agent
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20050267159A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Aaipharma, Inc. |
Magnesium complexes of S-omeprazole
|
US20050267157A1
(en)
*
|
2004-05-28 |
2005-12-01 |
David White |
Magnesium-S-omeprazole
|
EP1768668A2
(en)
|
2004-06-16 |
2007-04-04 |
Tap Pharmaceutical Products, Inc. |
Multiple ppi dosage form
|
CN1972928A
(zh)
*
|
2004-06-24 |
2007-05-30 |
阿斯利康(瑞典)有限公司 |
制备用于制备依美拉唑钠盐的结晶修饰物的新方法
|
ES2246149B1
(es)
*
|
2004-07-02 |
2007-06-01 |
Esteve Quimica, S.A. |
Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
WO2006073779A1
(en)
*
|
2004-12-30 |
2006-07-13 |
Transform Phamaceuticals, Inc. |
Novel omeprazole forms and related methods
|
ES2259269B1
(es)
|
2005-03-03 |
2007-11-01 |
Esteve Quimica, S.A. |
Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
|
US20060210637A1
(en)
*
|
2005-03-17 |
2006-09-21 |
Qpharma, Llc |
Stable tablet dosage forms of proton pump inhibitors
|
RU2007145207A
(ru)
*
|
2005-05-06 |
2009-06-20 |
Гленмарк Фармасьютикалз Лимитед (In) |
Стронциваемая соль эзомепразола, способ ее получения и содержащее ее фармацевтические композиции
|
US7563812B2
(en)
|
2005-06-15 |
2009-07-21 |
Hetero Drugs Limited |
Amorphous esomeprazole hydrate
|
EP1904064A4
(en)
*
|
2005-07-07 |
2009-12-02 |
Reddys Lab Ltd Dr |
OMEPRAZOLE OF FORM B
|
KR100641534B1
(ko)
|
2005-07-28 |
2006-11-01 |
한미약품 주식회사 |
에스오메프라졸 및 그의 염의 제조방법
|
US20070026071A1
(en)
*
|
2005-07-28 |
2007-02-01 |
Qpharma, Llc |
Magnesium salt proton pump inhibitor dosage forms
|
WO2007031845A2
(en)
*
|
2005-09-14 |
2007-03-22 |
Glenmark Pharmaceuticals Limited |
Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
|
AU2006299424A1
(en)
*
|
2005-10-06 |
2007-04-12 |
Auspex Pharmaceuticals, Inc. |
Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties
|
US7576219B2
(en)
*
|
2005-10-26 |
2009-08-18 |
Hanmi Pharm. Co., Ltd |
Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
|
RU2372345C1
(ru)
*
|
2005-10-26 |
2009-11-10 |
Ханми Фарм. Ко., Лтд. |
Стронциевая соль s-омепразола или ее гидрат, способ их получения и содержащая их фармацевтическая композиция
|
EP1801110A1
(en)
|
2005-12-22 |
2007-06-27 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Esomeprazole arginine salt
|
US7553857B2
(en)
*
|
2005-12-23 |
2009-06-30 |
Lek Pharmaceuticals D.D. |
S-omeprazole magnesium
|
CN100384839C
(zh)
*
|
2006-02-17 |
2008-04-30 |
中国科学院上海有机化学研究所 |
[(取代的吡啶基)甲基]亚磺酰基-1h-苯并咪唑类化合物及其对映体的锌盐的制备方法
|
US7579476B2
(en)
*
|
2006-02-24 |
2009-08-25 |
Praktikatalyst Pharma, Llc |
Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
|
US8063074B2
(en)
|
2006-05-04 |
2011-11-22 |
Dr. Reddy's Laboratories Limited |
Polymorphic forms of esomeprazole sodium
|
WO2007148213A2
(en)
*
|
2006-06-21 |
2007-12-27 |
Glenmark Pharmaceuticals Limited |
Novel polymorph of esomeprazole potassium and process for its preparation
|
WO2008067037A2
(en)
|
2006-10-05 |
2008-06-05 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
EP2086543A2
(en)
|
2006-10-27 |
2009-08-12 |
The Curators of the University of Missouri |
Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
|
EP1947099A1
(en)
*
|
2007-01-18 |
2008-07-23 |
LEK Pharmaceuticals D.D. |
Process for solvent removal from omeprazole salts
|
WO2008092939A2
(en)
|
2007-01-31 |
2008-08-07 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation
|
CA2678702A1
(en)
|
2007-02-21 |
2008-08-28 |
Cipla Limited |
Process for the preparation of esomeprazole magnesium dihydrate
|
KR101303813B1
(ko)
*
|
2007-04-16 |
2013-09-04 |
에스케이케미칼주식회사 |
라세믹 오메프라졸로부터 에스오메프라졸의 개선된제조방법
|
EP2000468A1
(en)
|
2007-05-09 |
2008-12-10 |
Dr. Reddy's Laboratories Ltd. |
Esomeprazole salts and processes for preparation thereof
|
EP2152691B1
(en)
*
|
2007-06-07 |
2011-11-23 |
Aurobindo Pharma Limited |
An improved process for preparing an optically active proton pump inhibitor
|
FR2920428B1
(fr)
*
|
2007-08-29 |
2012-06-15 |
Univ Rouen |
Procede de dedoublement de sels de l'omeprazole
|
WO2009047775A2
(en)
*
|
2007-10-08 |
2009-04-16 |
Hetero Drugs Limited |
Polymorphs of esomeprazole salts
|
KR20170097787A
(ko)
|
2007-10-12 |
2017-08-28 |
다케다 파마슈티칼스 유에스에이, 인코포레이티드 |
음식 섭취와 관계없이 위장 장애를 치료하는 방법
|
WO2009074997A2
(en)
*
|
2007-12-10 |
2009-06-18 |
Lee Pharma Ltd. |
A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate
|
WO2009099933A2
(en)
*
|
2008-02-01 |
2009-08-13 |
Dr. Reddy's Laboratories Ltd. |
Preparation of esomeprazole magnesium and hydrates thereof
|
US20090280173A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Ishwar Chauhan |
Multilayer Omeprazole Tablets
|
WO2009137648A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Aptapharma, Inc. |
Multilayer proton pump inhibitor tablets
|
EP2143722A1
(en)
|
2008-07-09 |
2010-01-13 |
Lek Pharmaceuticals D.D. |
Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
|
EP2147918A1
(en)
|
2008-07-21 |
2010-01-27 |
LEK Pharmaceuticals D.D. |
Process for the preparation of S-omeprazole magnesium in a stable form
|
KR20110079641A
(ko)
|
2008-09-09 |
2011-07-07 |
아스트라제네카 아베 |
제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
|
CN101391993B
(zh)
*
|
2008-10-28 |
2012-07-04 |
安徽美诺华药物化学有限公司 |
通过与(s)-(-)-1,1'-联萘-2,2'-二酚形成包合配合物制备s-奥美拉唑及其盐的方法
|
WO2010097583A1
(en)
|
2009-02-24 |
2010-09-02 |
Cipla Limited |
Esomeprazole potassium polymorph and its preparation
|
US20100267959A1
(en)
*
|
2009-04-15 |
2010-10-21 |
Glenmark Generics Limited |
Process for the preparation of esomeprazole magnesium dihydrate
|
WO2010122583A2
(en)
|
2009-04-24 |
2010-10-28 |
Rubicon Research Private Limited |
Oral pharmaceutical compositions of acid labile substances
|
EP2438057A4
(en)
*
|
2009-06-02 |
2013-12-25 |
Sun Pharmaceutical Ind Ltd |
PROCESS FOR PREPARING SULFOXIDE COMPOUNDS
|
CA2766524A1
(en)
*
|
2009-06-25 |
2010-12-29 |
Pozen Inc. |
Method for treating a patient in need of aspirin therapy
|
AU2010263304A1
(en)
|
2009-06-25 |
2012-02-02 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an NSAID-associated ulcer
|
WO2011012957A1
(en)
*
|
2009-07-29 |
2011-02-03 |
Orchid Chemicals & Pharmaceuticals Ltd |
An improved process for the preparation of esomeprazole magnesium dihydrate
|
EP2499125B1
(en)
|
2009-11-12 |
2016-01-27 |
Hetero Research Foundation |
Process for the resolution of omeprazole
|
SI2510089T1
(sl)
|
2009-12-08 |
2015-12-31 |
Codexis, Inc. |
Sinteza prazolnih spojin
|
US20110207779A1
(en)
*
|
2010-02-25 |
2011-08-25 |
Glenmark Generics Ltd |
Process for the preparation of esomeprazole magnesium
|
FR2959509B1
(fr)
|
2010-05-03 |
2012-07-13 |
Prod Chim Auxiliaires Et De Synthese |
Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole
|
CN102241668B
(zh)
*
|
2010-05-11 |
2015-11-25 |
中国科学院成都有机化学有限公司 |
S-奥美拉唑盐
|
EP2649187B1
(en)
|
2010-12-08 |
2017-11-22 |
Codexis, Inc. |
Biocatalysts and methods for the synthesis of armodafinil
|
CN102757421A
(zh)
*
|
2011-04-29 |
2012-10-31 |
江苏正大天晴药业股份有限公司 |
埃索美拉唑的纯化方法
|
CN104844577A
(zh)
*
|
2011-07-31 |
2015-08-19 |
连云港润众制药有限公司 |
埃索美拉唑镁的晶型
|
CN102936238B
(zh)
*
|
2011-11-25 |
2015-02-18 |
成都自豪药业有限公司 |
S-奥美拉唑镁盐的晶型及其制备方法
|
WO2013088272A1
(en)
*
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Pharmaceutical composition comprising esomeprazole magnesium dihydrate
|
EP2797600A4
(en)
|
2011-12-28 |
2015-09-16 |
Pozen Inc |
IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID
|
CN102584792B
(zh)
*
|
2012-01-06 |
2014-06-11 |
南京优科生物医药研究有限公司 |
制备高纯度的埃索美拉唑盐的方法
|
CN102993184A
(zh)
*
|
2013-01-08 |
2013-03-27 |
湖南方盛制药股份有限公司 |
一种埃索美拉唑及其镁盐三水合物的制备方法
|
CN104250243B
(zh)
*
|
2013-06-27 |
2016-12-28 |
四川国为制药有限公司 |
一种埃索美拉唑镁二水合物a晶型的制备方法
|
CN103570686B
(zh)
*
|
2013-10-14 |
2015-04-01 |
哈药集团技术中心 |
一种埃索美拉唑钠的合成及精制工艺
|
CN104725357A
(zh)
*
|
2013-12-24 |
2015-06-24 |
苏州联友制药技术有限公司 |
一种埃索美拉唑镁二水合物晶型b的制备方法
|
FR3018812A1
(fr)
*
|
2014-03-21 |
2015-09-25 |
Minakem |
Nouvelle phase intermediaire de la forme a du sel de magnesium dihydrate d'un enantiomere de l'omeprazole
|
CN104447699A
(zh)
*
|
2014-12-10 |
2015-03-25 |
哈药集团技术中心 |
一种埃索美拉唑镁三水合物的制备方法
|
CN105111188B
(zh)
*
|
2015-08-19 |
2018-01-19 |
扬子江药业集团有限公司 |
一种埃索美拉唑镁三水合物晶型的制备方法
|
WO2017145146A1
(en)
|
2016-02-25 |
2017-08-31 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
CN106397402B
(zh)
*
|
2016-08-30 |
2019-05-03 |
山东罗欣药业集团股份有限公司 |
一种埃索美拉唑镁晶型化合物及其制备方法
|
KR102006777B1
(ko)
|
2018-01-29 |
2019-10-08 |
주식회사 종근당 |
에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
|
KR102080023B1
(ko)
|
2018-01-29 |
2020-02-21 |
주식회사 종근당 |
에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
|
JP7506892B2
(ja)
*
|
2018-08-21 |
2024-06-27 |
東和薬品株式会社 |
化合物の特定形状の結晶及びその製造方法
|
KR102432084B1
(ko)
|
2021-11-16 |
2022-08-12 |
알리코제약(주) |
S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|